NCT03383861

Nutrition Status, BMD, and SSRIs

Nutrition Status, Bone Mass Density, and Selective Serotonin Reuptake Inhibitors

• Status: Terminated
• Phase: —
• Study type: Observational
• Enrollment: 13,027 (actual)
• Sponsor: University of New Mexico · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Accepted

Summary

The association between selective serotonin reuptake inhibitor (SSRI) use and bone mass density (BMD) has been debated. Some have suggested features of depression, which SSRIs are prescribed to treat, may be a cause of decreased BMD, such as poor overall food intake at the time of SSRI use. Our study seeks to determine whether SSRI use in adults is associated with lower than average BMD, and if there is an association between low micronutrient intake, SSRI use, and a low BMD.

Conditions

• BMD

Interventions

Type	Name	Description
DIAGNOSTIC_TEST	Dual-Energy X-ray Absorptiometry (DXA)	BMD t-score derived from DXA scan

Timeline

• Start date: 2005-01-01
• Primary completion: 2014-12-01
• Completion: 2014-12-01
• First posted: 2017-12-26
• Last updated: 2024-01-10

Regulatory

• FDA-regulated drug study